Betamethasone Microsphere (DE-102） Low Dose
01021103
Phase 3 small_molecule completed
Quick answer
Betamethasone Microsphere (DE-102） Low Dose for Diabetic Macular Edema is a Phase 3 program (small_molecule) at Santen Oy with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Santen Oy
- Indication
- Diabetic Macular Edema
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed